<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.0" article-type="research-article" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq. Bras. Cardiol.</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">db7HGQCLLCH5HtGgQFQ9WXQ</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2014001900014</article-id>
      <article-id pub-id-type="other">00014</article-id>
      <article-id pub-id-type="doi">10.5935/abc.20140099</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Viewpoint</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Valvular Heart Team</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Grinberg</surname>
            <given-names>Max</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <aff id="aff01">
          <institution content-type="orgname">Universidade de S&#227;o Paulo</institution>
          <institution content-type="orgdiv1">Faculdade de Medicina</institution>
          <institution content-type="orgdiv2">Hospital das Cl&#237;nicas</institution>
          <institution content-type="orgdiv3">Instituto do Cora&#231;&#227;o</institution>
          <addr-line>
            <named-content content-type="city">S&#227;o Paulo</named-content>
            <named-content content-type="state">SP</named-content>
          </addr-line>
          <country>Brazil</country>
          <institution content-type="original">InCor - HCFMUSP, S&#227;o Paulo, SP -
                  Brazil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c01"><bold>Mailing Address: Max Grinberg,</bold> Instituto do Cora&#231;&#227;o HC FMUSP, Rua Manoel
               Antonio Pinto, 4 ap. 21A, Parais&#243;polis. Postal Code 05663-020, S&#227;o Paulo, SP -
               Brazil. E-mail: <email>max@cardiol.br</email>; <email>grinberg@incor.usp.br</email>
           </corresp>
        <fn fn-type="conflict">
          <p>
            <bold>Potential Conflict of Interest</bold>
          </p>
          <p>No potential conflict of interest relevant to this article was reported.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <month>07</month>
        <year>2014</year>
      </pub-date>
      <volume>103</volume>
      <issue>1</issue>
      <fpage>e15</fpage>
      <lpage>e17</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>12</month>
          <year>2013</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>03</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>14</day>
          <month>03</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
                  Commons Attribution Non-Commercial License which permits unrestricted
                  non-commercial use, distribution, and reproduction in any medium, provided the
                  original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group xml:lang="en">
        <kwd>Aortic Valve Stenosis</kwd>
        <kwd>Cardiac Catheterization</kwd>
        <kwd>Heart Valve Prosthesis Implantation / methods</kwd>
        <kwd>Bioprosthesis</kwd>
        <kwd>Bioethics</kwd>
      </kwd-group>
      <counts>
        <fig-count count="0"/>
        <table-count count="0"/>
        <equation-count count="0"/>
        <ref-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <p>"An idealist is a person who helps other people to be prosperous."</p>
    <p>Henry Ford (1863 - 1947)</p>
    <p>The morality of medical practice is based on beneficence. The benefit is applicable to an
         organ, however, it is not enough. The safety of the procedure to the patient's life is a
            concern<xref ref-type="bibr" rid="B01">1</xref>.</p>
    <p>The sense of the usefulness of a therapeutic method is well validated by effect extent
         class I/IIa in a guideline, but he/she can be harmed when the unexpected wins
         predictability. The high complexity collects unquestionable medical indications that
         exhibit poor individual prognosis due to severe comorbidities<xref ref-type="bibr" rid="B02">2</xref>.</p>
    <p>In this comparison between illness and patient, the contraindication illustrates that the
         major limitations of physician are the limits of medical science. Fortunately, we live in a
         moment of endless technological innovations. Readily globalized, they expand the skill
         bounderies and, at the same time, they give vitality to the classic, for the ongoing
         development is imperative in medical science.</p>
    <p>A new horizon requires interdisciplinarity, which, in turn, demands interpersonal
         communication. In the interests of the best clinical practice for the patient, the
         propaedeutics communicates with clinical and scientific evidence that is understood as the
         clinical reasoning under the tension of the imminence of conduct, listening to the values
         and preferences of the patient. The efficient communication - to talk, to hear oneself (am
         I being objective?), to listen and to hear oneself hearing (am I connected?) - energizes
         the trespassing through the essential ethical tolls: benefit of method, patient safety and
         human character of medical science<xref ref-type="bibr" rid="B03">3</xref>.</p>
    <p>In recent millennium transition, the routine of "discussion of the case" included the gap
         between the availability of medical science and medical care to the elderly with aortic
         valve stenosis ineligible for conventional surgical treatment. However, already in the
         early years of the 21st century, the discomfort of "if we can't do-good, at least let us
         not do harm" was reduced by the prospects of support to this subgroup of patients by means
         of transcateter implant of a bioprosthesis.</p>
    <p>Due to the initial results, the sentence has changed, following the change of the paradigm,
         to "we can do-good, but we have to take care of its potential harm". The systematized
            research<xref ref-type="bibr" rid="B04">4</xref> proved the positive impact on the
         "hard" outcome pro-life and raised the likelihood of the certainty of benefit to B level.
         However, the best survival curve does not invalidate the uncertainties of complications
         related to innovation, a base of the modern concept of iatrogenesis<xref ref-type="bibr" rid="B05">5</xref>.</p>
    <p>Bedside conflicts arise between using an alternative method to conventional surgery to
         correct aortic valve hemodynamics and, at the same time, envision strong objections to
         satisfy the purpose both of survival and quality of life. They direct the physician to
         establish the applicable proportions of science and humanism, strongly advised by
         soliloquy, with the ontological component of ethics.</p>
    <p>The "I do-good to the patient because it crops out from being who I am and not just because
         I read the code of ethics" makes prudence and zeal flow in
         indicating/non-indicating/contraindicating depending on the symbolism of the Hippocratic
         oath. The resulting ordering of adjustments to the benefit ensures value for
         deliberation.</p>
    <p>It is worth remembering that, about 20 years ago, this moral plumbing occurred in
         establishing balloon catheter of mitral valvuloplasty and encouraged a close and
         progressive knowledge feedback and skill on the patient with mitral stenosis. Physician,
         surgeon, interventional cardiologist and echocardiographist got together and converted the
         field of the then innovation into an efficient relationship benefit/security that made it a
         rare AI recommendation in guideline of valvular heart disease. Currently, the transcateter
         implant of bioprosthetic in aortic position causes similar mobilization<xref ref-type="bibr" rid="B06">6</xref>. The search for answers to the questions brought
         about by the new therapeutic heritage recommends to appreciate it further than just a
         procedure. It is preferable to see it as a program comparable to a transplant<xref ref-type="bibr" rid="B07">7</xref>.</p>
    <p>The commitment of a collective of experts as far as the learning curve of this change of
         therapeutic standard in patients with valvular heart disease is concerned neither plastic
         nor native tissue replacement - is better structured in the formation of an
         interdisciplinary team to valvular heart disease. The team set-up replaces the one of
         disciplinary workgroup enough for sustainable routines by the coldness of reports and the
         monologue opinions juxtaposed.</p>
    <p>The interdisciplinary team for valvular heart disease links space and time. These
         dimensions make the refinement of movements and countermovements easier and to support
         excellence. Indication/non indication/contraindication may, therefore, be appropriately
         customized to the symptomatic elderly with aortic valve stenosis, respecting the enormous
         heterogeneity of the real world twinned by right to dignity.</p>
    <p>Transparency in interdisciplinary coordination of complementary <italic>expertises</italic>
         in patients with valvular heart disease is the raw material for the construction of a
         platform of clarity of tasks to be fulfilled, limits to be respected and performance levels
         to be achieved. Interdisciplinary meanings for the professional proficiency make the team
         an opinion maker.</p>
    <p>The interdisciplinary team for valvular heart disease confers nationality. The hierarchy
         between methods with flexibility in its borders, the tone for subjectivities (body
         weakness) and inaccurate objectivities (surgical risk scores), critical analysis on
         personal and literature results and the modulation to the sociocultural and economic
         develop the necessary fine tuning with Brazilian realities.</p>
    <p>The interdisciplinary team for valvular heart disease is greater than the sum of their
         participants, which does not happen with the working group. The expansion lies in the
         attitude of each member - sometimes as a disclosure, other as a receiver. I teach, you
         learn, he improves, we progress, is the conjugation intended from a system connected to
         attain the highest level of mutual understanding on cost-risk-effectiveness about the
         trinomial aortic valve stenosis -non valvular cardiac abnormalities-extra cardiac
         comorbidities.</p>
    <p>The interdisciplinary team to valvular heart disease thrusts the clippings out of interest
         the vertical provisions verticalized by the hyperspecialization turns to a horizontal
         solidarity position between one another, useful for the needs, preferences ad values of the
         Brazilian elderly</p>
    <p>The interdisciplinary team for valvular heart disease highlights the value of current
         cardiology as it extracts information from the three imaging giants - ultrasonography, CT
         scan and MRI - and introduces it into the hammer of decision making present in the
         calloused hands of sovereign clinic, powerful surgical clinic and the skillful
         interventionist cardiology.</p>
    <p>In short, the interdisciplinary team for valvular heart disease builds a strong
         interdisciplinarity. When exchanging not only methods but also concepts, the
            transdisciplinarity<xref ref-type="bibr" rid="B08">8</xref> becomes closer by using
         rigor together with fundamental concepts, the opening to the unknown and the tolerance
         toward the gaps of medical science based on evidence about practices that cannot be
         disproved by personal experience. The hybrid room is the emblem.</p>
    <p>It is known that languages are neither static nor closed. Loan words occur as the result of
         dominance over a particular segment of society. In this context, the niche of present
         medical science is influenced by the supremacy of English language literature. TAVI is an
         anglicism that was quietly incorporated. Just as we should not insist on a Brazilian
         acronym by repositioning letters - ITVA or IVAT -, It seems reasonable to us to adopt the
         globalized (and synthetic) name Heart Team to express an interdisciplinary team specialized
         in cardiology.</p>
    <p>The concept of Heart Team was revived less than a decade ago as a methodological imperative
         deriving from the SYNTAX study<xref ref-type="bibr" rid="B09">9</xref>. The name gained
         notoriety for its contribution to the discipline communication and has migrated from
         research to assistance fields. The Heart Team acquired high organizational value in
         valvular heart disease, being understood that its absence is an absolute contraindication
         to the bioprosthetic transcateter implant in aortic position<xref ref-type="bibr" rid="B10">10</xref>.</p>
    <p>I propose that the Heart Team expression that (in)vests the shirt on in reliable
         relationship in a interdisciplinary network and acquires scientific capital facilitator of
         complex deliberations before the symptomatic elderly suffering from aortic valve stenosis
         to be termed as Heart Valve Team (VHT).</p>
    <p>VHT specificity includes: a) bioprosthesis management techniques and improvement ; b)
         contributions from imaging methods; c) safety by reducing adversity; d) early and late
         results, including participation in records; e) propensity to the use transcateter implant
         under minor surgical risk.</p>
    <p>It is appropriate to emphasize that the VHT should not be viewed with an expiration date to
         be set by taking innovation for granted. The VHT means aggregation in favour for excellence
         in the attention given to grey areas experienced by patients with valvular heart disease
         with dubious issues according to valvular and/or non valvular cardiac and /or extra-cardiac
         complexities.</p>
    <p>Finally, the VHT does not reinvent the wheel. VHT rediscovers the union and the gathering
         of people that give vitality to the analysis of uncertainties, the overcoming of adversity
         and the extent of the benefit.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="financial-disclosure">
        <p>
          <bold>Sources of Funding</bold>
        </p>
        <p>There were no external funding sources for this study.</p>
      </fn>
      <fn fn-type="other">
        <p>
          <bold>Author contributions</bold>
        </p>
        <p>Conception and design of the research, Acquisition of data, Writing of the manuscript
               and Critical revision of the manuscript for intellectual content: Grinberg M.</p>
      </fn>
      <fn fn-type="other">
        <p>
          <bold>Study Association</bold>
        </p>
        <p>This study is not associated with any thesis or dissertation work.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <mixed-citation>1. Singer SJ, Vogus TJ. Safety climate research: taking stock and
               looking forward. BMJ Qual Saf. 2013;22(1):1-4.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singer</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Vogus</surname>
              <given-names>TJ</given-names>
            </name>
          </person-group>
          <article-title xml:lang="en">Safety climate research: taking stock and looking
                  forward</article-title>
          <source>BMJ Qual Saf</source>
          <year>2013</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>4</lpage>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <mixed-citation>2. Atwater BD, Da&#237; D, Allen-Lapointe NM, Al-Khatib SM, Zimmer LO,
               Sanders GD, et al. Is heart failure guideline adherence being underestimated? The
               impact of therapeutic contraindications. Am Heart J.
               2012;164(5):750-5.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Atwater</surname>
              <given-names>BD</given-names>
            </name>
            <name>
              <surname>Da&#237;</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Allen-Lapointe</surname>
              <given-names>NM</given-names>
            </name>
            <name>
              <surname>Al-Khatib</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Zimmer</surname>
              <given-names>LO</given-names>
            </name>
            <name>
              <surname>Sanders</surname>
              <given-names>GD</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title xml:lang="en">Is heart failure guideline adherence being
                  underestimated? The impact of therapeutic contraindications</article-title>
          <source>Am Heart J</source>
          <year>2012</year>
          <volume>164</volume>
          <issue>5</issue>
          <fpage>750</fpage>
          <lpage>755</lpage>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <mixed-citation>3. Grinberg M, Tarasoutchi F, Sampaio RO. Roteiro para resolu&#231;&#227;o de
               valvopatia (Resolva). Arq Bras Cardiol. 2011;97(4):e86-90.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grinberg</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tarasoutchi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Sampaio</surname>
              <given-names>RO</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Roteiro para resolu&#231;&#227;o de valvopatia
                  (Resolva)</article-title>
          <source>Arq Bras Cardiol</source>
          <year>2011</year>
          <volume>97</volume>
          <issue>4</issue>
          <fpage>e86</fpage>
          <lpage>e90</lpage>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <mixed-citation>4. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al;
               PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic
               stenosis in patients who cannot undergo surgery. N Engl J Med.
               2010;363(17):1597-607.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leon</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>DC</given-names>
            </name>
            <name>
              <surname>Moses</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Svensson</surname>
              <given-names>LG</given-names>
            </name>
            <etal>et al</etal>
            <collab>PARTNER Trial Investigators</collab>
          </person-group>
          <article-title xml:lang="en">Transcatheter aortic-valve implantation for aortic
                  stenosis in patients who cannot undergo surgery</article-title>
          <source>N Engl J Med</source>
          <year>2010</year>
          <volume>363</volume>
          <issue>17</issue>
          <fpage>1597</fpage>
          <lpage>1607</lpage>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <mixed-citation>5. Ligi I, Millet V, Sartor C, Jouve E, Tardieu S, Sambuc R, Simeoni U.
               Iatrogenic events in neonates: beneficial effects of prevention strategies and
               continuous monitoring. Pediatrics. 2010;126(6):e1461-8.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ligi</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Millet</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Sartor</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jouve</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tardieu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sambuc</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Simeoni</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title xml:lang="en">Iatrogenic events in neonates: beneficial effects of
                  prevention strategies and continuous monitoring</article-title>
          <source>Pediatrics</source>
          <year>2010</year>
          <volume>126</volume>
          <issue>6</issue>
          <fpage>e1461</fpage>
          <lpage>e1468</lpage>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <mixed-citation>6. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, et
               al. Percutaneous transarterial aortic valve replacement in selected high-risk
               patients with aortic stenosis. Circulation. 2007;116(7):755-63.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Webb</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Pasupati</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Humphries</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Altwegg</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>R</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title xml:lang="en">Percutaneous transarterial aortic valve replacement in
                  selected high-risk patients with aortic stenosis</article-title>
          <source>Circulation</source>
          <year>2007</year>
          <volume>116</volume>
          <issue>7</issue>
          <fpage>755</fpage>
          <lpage>763</lpage>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <mixed-citation>7. Mack MJ, Holmes Jr DR. Rational dispersion for the introduction of
               transcatheter valve therapy. JAMA. 2011;306(19):2149-50.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mack</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>DR</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title xml:lang="en">Rational dispersion for the introduction of
                  transcatheter valve therapy</article-title>
          <source>JAMA</source>
          <year>2011</year>
          <volume>306</volume>
          <issue>19</issue>
          <fpage>2149</fpage>
          <lpage>2150</lpage>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <mixed-citation>8. Sommermann A. Inter ou transdisciplinaridade? Da fragmenta&#231;&#227;o
               disciplinar ao novo di&#225;logo entre os saberes. S&#227;o Paulo: Paulus;
               2006.</mixed-citation>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sommermann</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <source xml:lang="pt">Inter ou transdisciplinaridade? Da fragmenta&#231;&#227;o disciplinar ao
                  novo di&#225;logo entre os saberes</source>
          <publisher-loc>S&#227;o Paulo</publisher-loc>
          <publisher-name>Paulus</publisher-name>
          <year>2006</year>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <mixed-citation>9. Nallamothu BK, Cohen DJ. No ''I'' in heart team: incentivizing
               multidisciplinary care in cardiovascular medicine. Circ Cardiovasc Qual Outcomes.
               2012;5(3):410-3.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nallamothu</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>DJ</given-names>
            </name>
          </person-group>
          <article-title xml:lang="en">No ''I'' in heart team: incentivizing multidisciplinary
                  care in cardiovascular medicine</article-title>
          <source>Circ Cardiovasc Qual Outcomes</source>
          <year>2012</year>
          <volume>5</volume>
          <issue>3</issue>
          <fpage>410</fpage>
          <lpage>413</lpage>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <mixed-citation>10. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Bar&#243;n-Esquivias G,
               Baumgartner H, et al; Joint Task Force on the Management of Valvular Heart Disease of
               the European Society of Cardiology (ESC); European Association for Cardio-Thoracic
               Surgery (EACTS). Guidelines on the management of valvular heart disease (version
               2012). Eur Heart J. 2012;33(19):2451-96.</mixed-citation>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vahanian</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alfieri</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Andreotti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Antunes</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Bar&#243;n-Esquivias</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Baumgartner</surname>
              <given-names>H</given-names>
            </name>
            <etal>et al</etal>
            <collab>Joint Task Force on the Management of Valvular Heart Disease of the
                     European Society of Cardiology</collab>
            <collab>European Association for Cardio-Thoracic Surgery</collab>
          </person-group>
          <article-title xml:lang="en">Guidelines on the management of valvular heart disease
                  (version 2012)</article-title>
          <source>Eur Heart J</source>
          <year>2012</year>
          <volume>33</volume>
          <issue>19</issue>
          <fpage>2451</fpage>
          <lpage>2496</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="SA1" xml:lang="pt">
    <front-stub>
      <title-group>
        <article-title xml:lang="pt">Valvular Heart Team</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Grinberg</surname>
            <given-names>Max</given-names>
          </name>
          <xref ref-type="corresp" rid="c02"/>
        </contrib>
        <aff>
          <institution content-type="orgname">HCFMUSP</institution>
          <institution content-type="orgdiv1">InCor</institution>
          <addr-line>
            <named-content content-type="city">S&#227;o Paulo</named-content>
            <named-content content-type="state">SP</named-content>
          </addr-line>
          <country>Brasil</country>
          <institution content-type="original">InCor - HCFMUSP, S&#227;o Paulo, SP -
                  Brasil</institution>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c02"><bold>Correspond&#234;ncia: Max Grinberg,</bold> Instituto do Cora&#231;&#227;o HC FMUSP, Rua Manoel
               Antonio Pinto, 4 ap. 21A, Parais&#243;polis. CEP 05663-020, S&#227;o Paulo, SP - Brasil.
               E-mail: <email>max@cardiol.br</email>; <email>grinberg@incor.usp.br</email>
           </corresp>
        <fn fn-type="conflict">
          <p>
            <bold>Potencial conflito de interesse</bold>
          </p>
          <p>Declaro n&#227;o haver conflito de interesses pertinentes.</p>
        </fn>
      </author-notes>
      <kwd-group xml:lang="pt">
        <kwd>Estenose da Valva A&#243;rtica</kwd>
        <kwd>Cateterismo Card&#237;aco</kwd>
        <kwd>Implante de Pr&#243;tese de Valva Card&#237;aca /m&#233;todos</kwd>
        <kwd>Biopr&#243;tese</kwd>
        <kwd>Bio&#233;tica</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>"Idealista &#233; aquele que ajuda o outro a prosperar."</p>
      <p>Henry Ford (1863 - 1947)</p>
      <p>A moralidade da pr&#225;tica m&#233;dica fundamenta-se na benefic&#234;ncia. O benef&#237;cio aplic&#225;vel a um
            &#243;rg&#227;o, todavia, n&#227;o basta. H&#225; que se preocupar com a seguran&#231;a do procedimento para a
            vida do paciente<xref ref-type="bibr" rid="B01">1</xref>.</p>
      <p>O sentido da utilidade de um m&#233;todo terap&#234;utico &#233; bem validado pela dimens&#227;o de efeito
            classe I/IIa numa diretriz, mas ele pode ficar prejudicado quando o imprevisto ganha
            previsibilidade. A alta complexidade coleciona indica&#231;&#245;es terap&#234;uticas inquestion&#225;veis
            que apresentam mau progn&#243;stico individual em fun&#231;&#227;o de graves comorbidades<xref ref-type="bibr" rid="B02">2</xref>.</p>
      <p>Neste cotejamento entre doen&#231;a e doente, a contraindica&#231;&#227;o ilustra que a maior limita&#231;&#227;o
            do m&#233;dico &#233; o limite da medicina. Felizmente, vivemos um presente incessante de
            inova&#231;&#245;es tecnol&#243;gicas. Prontamente globalizadas, elas ampliam as fronteiras das
            habilidades e, ao mesmo tempo, vitalizam o cl&#225;ssico, pois o cont&#237;nuo &#233; imperativo na
            medicina.</p>
      <p>Um novo horizonte requer a interdisciplinaridade, que, por sua vez, &#233; exigente da
            comunica&#231;&#227;o interpessoal. Em prol do bem cl&#237;nico melhor para o paciente, a proped&#234;utica
            comunica-se com a evid&#234;ncia cl&#237;nico-cient&#237;fica que se entende com o racioc&#237;nio cl&#237;nico
            sob a tens&#227;o da imin&#234;ncia de conduta, dando ouvidos a valores e prefer&#234;ncias do
            paciente. A interlocu&#231;&#227;o eficiente - falar, ouvir-se falar (estou sendo objetivo?),
            ouvir e ouvir-se ouvir (estou conectado?) - energiza o transpasse pelos ped&#225;gios &#233;ticos
            essenciais: benef&#237;cio do m&#233;todo, seguran&#231;a para o paciente e car&#225;ter humano da
               medicina<xref ref-type="bibr" rid="B03">3</xref>.</p>
      <p>Na recente transi&#231;&#227;o de mil&#234;nio, a rotina de "discuss&#227;o do caso" inclu&#237;a o desn&#237;vel
            entre disponibilidades da medicina e aten&#231;&#227;o m&#233;dica ao idoso com estenose valvar a&#243;rtica
            ineleg&#237;vel para tratamento cir&#250;rgico convencional. Mas, j&#225; nos primeiros anos do s&#233;culo
            XXI, o desconforto do "se n&#227;o podemos fazer o bem, pelo menos que n&#227;o fa&#231;amos o mal"
            reduziu-se pelo panorama de amparo a esse subgrupo de pacientes pelo implante
            transcateter de uma biopr&#243;tese.</p>
      <p>Pelos resultados iniciais, a frase mudou, acompanhando a mudan&#231;a de paradigma, para
            "podemos fazer o bem, mas temos que cuidar do seu potencial de mal". A pesquisa
               sistematizada<xref ref-type="bibr" rid="B04">4</xref> comprovou o impacto positivo
            sobre o desfecho "duro" pr&#243;-vida e elevou a probabilidade de certeza do benef&#237;cio para o
            n&#237;vel B. Contudo, a melhor curva de sobrevida n&#227;o invalida as incertezas das
            intercorr&#234;ncias &#224; inova&#231;&#227;o, um fundamento do conceito moderno de iatrogenia<xref ref-type="bibr" rid="B05">5</xref>.</p>
      <p>Resultam conflitos da beira do leito entre dispor de um m&#233;todo alternativo ao cir&#250;rgico
            convencional para corrigir a hemodin&#226;mica valvar a&#243;rtica e, ao mesmo tempo, vislumbrar
            fortes obje&#231;&#245;es a satisfazer o objetivo de sobrevida e qualidade de vida. Eles
            direcionam o m&#233;dico a organizar as propor&#231;&#245;es aplic&#225;veis de ci&#234;ncia e de humanismo
            firmemente aconselhado pelo solil&#243;quio com o componente ontol&#243;gico da &#233;tica.</p>
      <p>O "fa&#231;o o bem para o paciente porque aflora do ser que sou e n&#227;o apenas porque li o
            c&#243;digo de &#233;tica" faz fluir a prud&#234;ncia e o zelo na indica&#231;&#227;o/n&#227;o
            indica&#231;&#227;o/contraindica&#231;&#227;o conforme o simbolismo do juramento de Hip&#243;crates. A
            consequente ordena&#231;&#227;o dos ajustes ao benef&#237;cio/seguran&#231;a assegura valor &#224;
            delibera&#231;&#227;o.</p>
      <p>Recorde-se que, h&#225; cerca de 20 anos, essa canaliza&#231;&#227;o moral ocorreu na institui&#231;&#227;o da
            valvoplastia mitral por cateter-bal&#227;o e estimulou uma estreita e progressista
            retroalimenta&#231;&#227;o de conhecimento e de habilidade sobre o portador de estenose mitral.
            Cl&#237;nico, cirurgi&#227;o, cardiologista intervencionista e ecocardiografista harmonizaram-se e
            converteram o dom&#237;nio da ent&#227;o inova&#231;&#227;o em eficiente rela&#231;&#227;o benef&#237;cio/seguran&#231;a que a
            tornou uma rara recomenda&#231;&#227;o IA em diretriz de valvopatia. Atualmente, o implante
            transcateter de biopr&#243;tese em posi&#231;&#227;o a&#243;rtica provoca mobiliza&#231;&#227;o an&#225;loga<xref ref-type="bibr" rid="B06">6</xref>. A busca pelas respostas &#224;s quest&#245;es trazidas pelo
            novo patrim&#244;nio terap&#234;utico recomenda perceb&#234;-lo mais do que um procedimento. &#201;
            prefer&#237;vel enxerg&#225;-lo na condi&#231;&#227;o de um programa compar&#225;vel a um transplante<xref ref-type="bibr" rid="B07">7</xref>.</p>
      <p>O comprometimento de um coletivo de especialistas na curva de aprendizado dessa mudan&#231;a
            de padr&#227;o terap&#234;utico em valvopatia - nem pl&#225;stica nem substitui&#231;&#227;o do tecido nativo -
            fica mais bem estruturado na forma&#231;&#227;o de uma equipe interdisciplinar para valvopatia. A
            concep&#231;&#227;o de equipe substitui a de grupo de trabalho disciplinar suficiente para as
            rotinas sustent&#225;veis pela frieza de laudos e pelos pareceres mon&#243;logos justapostos.</p>
      <p>A equipe interdisciplinar para valvopatia associa espa&#231;o e tempo. Essas dimens&#245;es
            facilitam o refinamento dos movimentos e contramovimentos para firmar excel&#234;ncia.
            Indica&#231;&#227;o/n&#227;o indica&#231;&#227;o/contraindica&#231;&#227;o podem, dessa maneira, ser personalizadas
            adequadamente para o idoso sintom&#225;tico portador de estenose valvar a&#243;rtica, respeitando
            o mundo real de enorme heterogeneidade irmanada pelo direito &#224; dignidade.</p>
      <p>A transpar&#234;ncia nas articula&#231;&#245;es interdisciplinares de <italic>expertises</italic>
            complementares em valvopatia &#233; mat&#233;ria-prima para a constru&#231;&#227;o de uma plataforma de
            clareza de tarefas a serem cumpridas, de limites a serem respeitados e de n&#237;veis de
            desempenho a serem alcan&#231;ados. Significados interdisciplinares para a profici&#234;ncia
            profissional fazem da equipe um formador de opini&#227;o.</p>
      <p>A equipe interdisciplinar para valvopatia confere nacionalidade. A hierarquia entre
            m&#233;todos com flexibilidade de suas fronteiras, o tom para subjetividades (fragilidade
            corporal) e objetividades imprecisas (escores de risco cir&#250;rgico), a an&#225;lise cr&#237;tica
            sobre resultados pr&#243;prios e da literatura e a modula&#231;&#227;o ao econ&#244;mico-sociocultural
            desenvolvem a necess&#225;ria sintonia fina com as realidades brasileiras.</p>
      <p>A equipe interdisciplinar para valvopatia &#233; maior do que a soma de seus part&#237;cipes, o
            que n&#227;o acontece com o grupo de trabalho. A expans&#227;o ocorre na atitude de altern&#226;ncia de
            cada membro - ora expositor, ora receptor. Eu ensino, tu aprendes, ele melhora, n&#243;s
            progredimos &#233; conjuga&#231;&#227;o que se pretende de um sistema conectado para atingir o m&#225;ximo
            n&#237;vel da compreens&#227;o m&#250;tua sobre custo-risco-efetividade acerca do trin&#244;mio estenose
            valvar a&#243;rtica -anormalidades card&#237;acas n&#227;o valvares-comorbidades extracard&#237;acas.</p>
      <p>A equipe interdisciplinar para valvopatia anima os recortes de saber de interesse e os
            rearranja de modo que as disposi&#231;&#245;es unit&#225;rias verticalizadas pela hiperespecializa&#231;&#227;o
            voltem-se para uma horizontalidade solid&#225;ria entre si com validade para as necessidades,
            prefer&#234;ncias e valores do idoso brasileiro.</p>
      <p>A equipe interdisciplinar para valvopatia d&#225; destaque a um valor da cardiologia atual,
            na medida em que extrai informa&#231;&#227;o dos tr&#234;s gigantes da imagem - ultrassonografia,
            tomografia e resson&#226;ncia - e a insere no martelo da tomada de decis&#227;o presente nas m&#227;os
            calejadas da cl&#237;nica soberana, da poderosa cl&#237;nica cir&#250;rgica e da habilidosa cardiologia
            intervencionista.</p>
      <p>Em suma, a equipe interdisciplinar para valvopatia ambienta uma interdisciplinaridade
            forte. Ao intercambiar n&#227;o somente m&#233;todos, mas tamb&#233;m conceitos, ela se aproxima da
               transdisciplinaridade<xref ref-type="bibr" rid="B08">8</xref> pela pr&#225;tica do rigor
            com conceitos fundamentais, pela abertura ao desconhecido e pela toler&#226;ncia &#224;s lacunas
            da medicina baseada em evid&#234;ncias sobre pr&#225;ticas que n&#227;o podem ser refutadas da
            experi&#234;ncia pr&#243;pria. A sala h&#237;brida &#233; o emblema.</p>
      <p>Sabe-se que os idiomas n&#227;o s&#227;o nem est&#225;ticos nem fechados. Os estrangeirismos ocorrem
            como fruto de um dom&#237;nio sobre determinado segmento da sociedade. Nesse contexto, o
            nicho da medicina atual &#233; influenciado pela supremacia da literatura de l&#237;ngua inglesa.
            TAVI &#233; anglicismo que foi tranquilamente incorporado. Assim como n&#227;o devemos insistir
            numa sigla &#224; brasileira com reposicionamento das letras - ITVA ou IVAT -, parece-nos
            razo&#225;vel adotar a globalizada (e sint&#233;tica) denomina&#231;&#227;o <italic>Heart Team</italic> para
            expressarmos uma equipe interdisciplinar atuante em cardiologia.</p>
      <p>O conceito de <italic>Heart Team</italic> foi reavivado h&#225; menos de uma d&#233;cada como
            for&#231;a metodol&#243;gica do estudo SYNTAX<xref ref-type="bibr" rid="B09">9</xref>. O nome
            ganhou notoriedade pela contribui&#231;&#227;o &#224; interlocu&#231;&#227;o disciplinar e migrou da pesquisa
            para a assist&#234;ncia. O <italic>Heart Team</italic> adquiriu alto valor organizacional em
            valvopatia, entendendo-se que a sua inexist&#234;ncia &#233; contraindica&#231;&#227;o absoluta ao implante
            transcateter de biopr&#243;tese em posi&#231;&#227;o a&#243;rtica<xref ref-type="bibr" rid="B10">10</xref>.</p>
      <p>Proponho que o <italic>Heart Team</italic> que (in) veste a camisa em confi&#225;vel
            relacionamento em rede interdisciplinar e adquire capital cient&#237;fico facilitador de
            delibera&#231;&#245;es complexas perante o idoso sintom&#225;tico portador de estenose valvar a&#243;rtica
            seja denominado <italic>Valvular Heart Team</italic> (VHT).</p>
      <p>A especificidade do VHT inclui: a) t&#233;cnicas de manejo e aperfei&#231;oamento da biopr&#243;tese;
            b) contribui&#231;&#227;o das modalidades de imagem; c) seguran&#231;a pela redu&#231;&#227;o de adversidades; d)
            resultados precoces e tardios, incluindo a participa&#231;&#227;o em registros; e) tend&#234;ncias &#224;
            utiliza&#231;&#227;o do implante transcateter sob menor risco cir&#250;rgico.</p>
      <p>&#201; oportuno ressaltar que o VHT n&#227;o deve ser visto com prazo de validade a ser marcado
            pela rotiniza&#231;&#227;o da inova&#231;&#227;o. O VHT &#233; agrega&#231;&#227;o em prol da excel&#234;ncia na aten&#231;&#227;o &#224;s
            zonas cinzentas habitadas pelo portador de valvopatia com quest&#245;es d&#250;bias em fun&#231;&#227;o de
            complexidades valvares e/ou card&#237;acas n&#227;o valvares e/ou extracard&#237;acas.</p>
      <p>Finalmente, o VHT n&#227;o reinventa a roda. O VHT redescobre a uni&#227;o e a reuni&#227;o de pessoas
            que d&#227;o vitalidade &#224; an&#225;lise das incertezas, &#224; supera&#231;&#227;o das adversidades e ao alcance
            do benef&#237;cio.</p>
    </body>
    <back>
      <fn-group>
        <fn fn-type="other">
          <p>
            <bold>Vincula&#231;&#227;o acad&#234;mica</bold>
          </p>
          <p>N&#227;o h&#225; vincula&#231;&#227;o deste estudo a programas de p&#243;s-gradua&#231;&#227;o.</p>
        </fn>
        <fn fn-type="con">
          <p>
            <bold>Contribui&#231;&#227;o dos autores</bold>
          </p>
          <p>Concep&#231;&#227;o e desenho da pesquisa, Obten&#231;&#227;o de dados, Reda&#231;&#227;o do manuscrito e
                  Revis&#227;o cr&#237;tica do manuscrito quanto ao conte&#250;do intelectual importante: Grinberg
                  M.</p>
        </fn>
        <fn fn-type="financial-disclosure">
          <p>
            <bold>Fontes de financiamento</bold>
          </p>
          <p>O presente estudo n&#227;o teve fontes de financiamento externas.</p>
        </fn>
      </fn-group>
    </back>
  </sub-article>
</article>
